Welcome to LookChem.com Sign In|Join Free
  • or
di-tert-butyl 3-methyl hexahydropyridazine-1,2,3-tricarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

174497-80-4

Post Buying Request

174497-80-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

174497-80-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 174497-80-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,4,9 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 174497-80:
(8*1)+(7*7)+(6*4)+(5*4)+(4*9)+(3*7)+(2*8)+(1*0)=174
174 % 10 = 4
So 174497-80-4 is a valid CAS Registry Number.

174497-80-4Downstream Products

174497-80-4Relevant academic research and scientific papers

MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES

-

Paragraph 0390, (2017/08/01)

Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Synthesis of the southern tripeptide (C1-N12) of sanglifehrins using asymmetric organocatalysis

Radhika, Laghuvarapu,Chandrasekhar, Srivari

supporting information, p. 3602 - 3609 (2015/08/11)

The tripeptide southern region of the novel cyclophilin binding natural product macrolides, namely sanglifehrins, is synthesized involving asymmetric organocatalysis as chirality-inducing step. List's asymmetric α-amination was used in the synthesis of th

MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES

-

Page/Page column 140; 141, (2014/01/08)

Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES

-

Paragraph 308; 309, (2014/01/08)

Provided are compounds of Formula I and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Synthesis of the tripeptide domain of sanglifehrins using asymmetric phase-transfer catalysis

White, James D.,Suttisintong, Khomson

, p. 2757 - 2762 (2013/04/23)

The tripeptide (S)-valinyl-(S)-m-hydroxyphenylalanyl-(3S)-piperazate common to immunosuppressant sanglifehrins was synthesized from the constituent amino acid residues in nine steps and 42% overall yield. A key construction was the installation of (S) absolute configuration in m-hydroxyphenylalanine using asymmetric phase-transfer catalysis in the presence of N-(1-naphthyl) cinchonidinium bromide. Cbz-protected (S)-valine was first coupled to the amino group of (S)-m-triisopropylsilyloxyphenylalanine tert-butyl ester, and the resulting dipeptide after ester cleavage was linked to (3S)-methyl piperazate.

Synthesis of cyclic α-hydrazino acids

Duttagupta, Indranil,Goswami, Koushik,Sinha, Surajit

, p. 8347 - 8357 (2012/09/21)

Synthesis of five-, six-, seven-, eight-, and nine-membered cyclic α-hydrazino acids from a common starting material 'diethylmalonate' with 26, 16, 34, 13.5, and 13.33% overall yields is described. Sequential allylation or homoallylation and electrophilic amination followed by cyclization gave the desired rings. The methyl esters of eight- and nine-membered rings were synthesized by RCM and the corresponding free acids were generated after hydrolysis in the presence of 1 M BBr3 solution in DCM.

Ruthenium tetroxide oxidation of N,N'-Diboc hexahydropyridazines

Kaname, Mamoru,Yoshifuji, Shigeyuki,Sashida, Haruki

experimental part, p. 647 - 658 (2009/12/26)

The ruthenium tetroxide (RuO4) oxidation of the 3-substituted N,N'-diBochexahydropyridazines gave the 6-oxohexahydropyridazines in good to high yields, whereas the oxidation of the unsubstituted ones also gave the 3,6-dioxo derivatives. The 3,6

A convergent three-component total synthesis of the powerful immunosuppressant (-)-sanglifehrin A

Paquette, Leo A.,Duan, Maosheng,Konetzki, Ingo,Kempmann, Christoph

, p. 4257 - 4270 (2007/10/03)

The potent immunosuppressive agent (-)-sanglifehrin A (5), initially discovered in a soil sample from Malawi, has been synthesized in a highly conver soil gent and stereocontrolled manner. The enantioselective approach relies on initial construction of th

Enantioselective synthesis of (3R)- and (3S)-piperazic acids. The comparative unimportance of DMPU mediated retro-hydrazination

Hale, Karl J.,Cai, Jiaqiang,Delisser, Vern,Manaviazar, Soraya,Peak, S. Andrew,Bhatia, Gurpreet S.,Collins, Timothy C.,Jogiya, Neha

, p. 1047 - 1068 (2007/10/03)

In response to a recent literature report by Decicco and Leathers, the work of Hale, Delisser, and Manaviazar (1992) on the asymmetric synthesis of (3R)- and (3S)-piperazic acids has been reinvestigated, and the originally claimed product yields fully substantiated. The claims made in reference 13 about the proportions of cyclised product 6 and starting bromide 20 isolated from the low temperature electrophilic hydrazination-nucleophilic cyclisation of 20 with di-t-butylazodicarboxylate (DBAD) and DMPU as an additive are inaccurate. The retro-hydrazination reaction that they claim is problematic when DMPU is added to the hydrazinated reaction mixture has been demonstrated not to have a seriously detrimental effect on cyclisation product yield and to be unimportant. The other main ion of reference 13, that the electrophilic hydrazination and nucleophilic cyclisation of 20 gives 6 in 91% isolated yield when n-Bu4NI is employed as an additive (instead of DMPU) has also been shown to be in error. We have carefully repeated a scaled-down version of the n-Bu4NI catalysed procedure and have found that 6 is generally isolated in yields of 50-56% after flash chromatography. We have concluded that n-Bu4NI does not significantly increase the yields of cyclisation products 6 or 17 when it is employed as a cyclisation additive. Herein, we report details of our two preferred 'crude' experimental procedures for preparing the enantiomers of piperazic acid in high optical purity, neither of which requires chromatographic purification of the reaction intermediates en route. Both these preferred 'crude' methods for preparing 11 and 19 have been consistently reproduced many times in these laboratories over the past few years. In our view, they remain the most expedient and highest yielding methods currently available for obtaining 11 and 19 in high optical purity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 174497-80-4